Beiersdorf AG and Rubedo Life Sciences, Inc., a Sunnyvale, Calif.-based biopharma firm focused on keeping people “biologically young,” have partnered for a multi-year deal to develop anti-aging solutions for the global face market, Beiersdorf announced on 23 April. “The goal of this collaboration is to make use of Rubedo’s cutting-edge research in the field of cellular senescence and Beiersdorf’s market presence to develop groundbreaking anti-aging products,” the Hamburg, Germany-based firm says. Novel compounds with senolytic and anti-inflammatory properties will be sourced from Rubedo’s topical dermatology program.
One day earlier, Beiersdorf announced the launch of a new anti-aging product, NIVEA Q10 Dual Action Serum, that combines coenzyme...




